Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
Gruber
S A
SA
Department of Surgery, University of Minnesota, Minneapolis.
Pescovitz
M
M
Simmons
R L
RL
Najarian
J S
JS
Ascher
N L
NL
Payne
W D
WD
Sutherland
D E
DE
Elick
B
B
Fryd
D S
DS
D000961:Antilymphocyte Serum / Q000009:adverse effects* / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000209:etiology; D013923:Thromboembolism / Q000139:chemically induced / Q000209:etiology*; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine